AbCellera’s T-cell engager (TCE) platform has reeled in a second client this summer, with Vertex Pharmaceuticals ...

There are other reasons to pay attention to Viking Therapeutics.

AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other ...

A seasoned leader in refining, renewable fuels, and clean-energy infrastructure joins Alléo as it scales its proprietary ...

AbCellera (Nasdaq: ABCL) today announced a collaboration with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) to research, develop, manufacture, and commercialize multispecific T-cell engagers ...

Explore the techniques and setup choices behind the smooth driving experience and realistic feel of Rev To Vertex.

Biogen has found a successor to longtime legal chief Susan Alexander, tapping former Vertex Pharmaceuticals executive and ...

CRISPR Therapeutics offers a diversified gene-editing pipeline, with CASGEVY as its lead asset and multiple upcoming ...

Please note this event is being recorded. I would now like to turn the conference over to Ms. Susie Lisa. Please go ahead. Thanks, Chuck. Good afternoon, everyone, and thank you for joining us on ...

Key Points Interested in Vertex Pharmaceuticals Incorporated? Here are five stocks we like better. Vertex Pharmaceuticals agreed to buy Crinetics Pharmaceuticals for $85 per share in cash, valuing the ...

WSW, NY, July 22nd, 2026, FinanceWireTen billion dollars. That is what Vertex Pharmaceuticals (Nasdaq: VRTX) agreed to pay ...

Flush with GLP-1 cash and pipeline success, Eli Lilly rose from 16th to first over five years in Norstella’s inaugural ...